Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
MindPetal Secures Major Application Portfolio Support Task with Department of Labor's OSHA
-
Metawells Oil & Gas Inc. Enters Into Definitive Agreement to Acquire Global Oil & Gas Recovery Corp., Adding Technology That Eliminates the Flaring & Venting of Waste Methane Gas
-
The Home Depot Declares First Quarter Dividend of $2.25
-
FLOWERS FOODS, INC. REPORTS FIRST QUARTER 2024 RESULTS
-
Zehl & Associates is Finalist for National Law Journal Elite Trial Lawyers Award
-
Comstock Announces Kickoff to Summerbration 2024 at Reston Station
-
Comstock Announces Kickoff to Summerbration 2024 at Loudoun Station
-
Exicure, Inc. Reports Third Quarter 2023 Financial Results
-
KBRA Assigns Preliminary Ratings to Verdant Receivables 2024-1 LLC
-
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
-
Despegar.com Announces 1Q24 Financial Results
-
F3 Announces Revised Pricing of Bought Deal Private Placement for Gross Proceeds of Over C$10.0 Million
-
Kimberly-Clark Professional(TM) Announces Greenovation Awards for Sustainability Leadership and Waste Reduction
-
Fortrea Appoints Machelle Sanders to Board of Directors
-
NextNav Announces Appointment of Jonathan Marcus to Board of Directors
-
Take-Two Interactive Software, Inc. Reports Results for Fourth Quarter and Fiscal Year 2024
-
Merit Medical Shareholders Elect Silvia M. Perez as New Director
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
-
Airbnb to Participate in the Bernstein 40th Annual Strategic Decisions Conference 2024
-
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
-
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
-
CRACKER BARREL PROVIDES UPDATE ON STRATEGIC TRANSFORMATION PLAN AND ANNOUNCES CAPITAL ALLOCATION CHANGES TO DRIVE SUSTAINABLE LONG-TERM VALUE CREATION
-
Lam Research Corporation Declares Quarterly Dividend
-
EVERTEC Announces Successful Repricing of Existing Term Loan B
-
Merchants Bancorp Declares Quarterly Common and Preferred Dividends
-
National Storage Affiliates Trust Announces Quarterly Dividends
-
BILL to Participate in Upcoming Investor Conferences
-
Arcadium Lithium's CEO Paul Graves to Speak at Multiple Upcoming Conferences in the Second Quarter
-
Box Announces Appointment of Steve Murphy, CEO of Epicor Software, to its Board of Directors
-
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Interface Declares Regular Quarterly Dividend
-
Domo Announces New Omnichannel Optimization Solutions For Retailers
-
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer
-
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
-
Build-A-Bear Workshop to Announce First Quarter Fiscal 2024 Results and Host Investor Conference Call on May 30, 2024
-
PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders
-
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets
-
Savara Announces New Employment Inducement Grant
-
Rapid7 to Attend Upcoming Investor Conferences
-
Epsilon Announces 2024 AGM Results
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
-
Ulta Beauty to Report First Quarter Fiscal 2024 Results on May 30, 2024
-
ZimVie to Participate in Upcoming Investor Conferences
-
TEN Ltd. Announces Delivery of Six Environmentally Friendly Vessels Since the Beginning of 2024
-
Option Care Health to Participate in Upcoming Investor Conferences
-
Earlyworks Announces Completion of ADS Ratio Change
-
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
-
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
-
New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer


